sirisha's blog

EARLY USE OF NSAID'S MIGHT PREVENT ALZHEIMER'S DISEASE..

As everyone are aware of Alzheimer's disease, recent news is that early use of NSAID's might prevent this disease. Its still under clinical investigation, the mice being the experimental animals.

Alzheimer’s disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks.

POLYPILL...

Dear all..This is somewhat introduction to my previous blog "ExforgeHCT". 3 drugs within same pill leads to the concept of Polypill.

Whats a Polypill?
A polypill is dosage form or medication containing two or more active drugs. These are generally made on the intention of reducing the number of tablets or capsules to be taken.

Influenza A (H1N1) 2009 Monovalent Vaccine

Influenza A (H1N1) 2009 Monovalent Vaccine is developed by Novartis Vaccines and Diagnostics Ltd. Given as suspension for Intramuscular Injection

INDICATIONS AND USAGE
• Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 4 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus

FDA approves STELARA

In a recent news..FDA approved Stelara(ustekinumab)for adults to treat moderate to severe form of PSORIASIS.Plaque psoriasis is an immune system disorder that results in the rapid overproduction of skin cells. About 6 million people in the United States have plaque psoriasis which is characterized by thickened patches of inflamed, red skin, often covered with silvery scales.

TAMIFLU...SIDE EFFECTS..

With the severe spreading of Swine flu..Doctors are prescribing TAMIFLU as preventive medication..But everyone should be aware of possible side effects by using the drug..Let's see some of the possible side effects of tamiflu..

Encourage patients to seek medical attention right away if any of these SEVERE side effects were observed..

Orchid's Piperacillin-Tazobactam ANDA gets FDA nod

India based pharma major - Orchid Chemicals and Pharmaceuticals has received approvals from FDA for its ANDAs for Piperacillin and Tazobactam. These are available in both vial and Bulk Dosage forms. Orchid is the "first applicant" and a 180day generic drug exclusivity was granted by FDA. The Indian firm has marketing and distribution partnership with Apotex a US based company. Speaking at a conference, Mr K Raghavendra Rao, Managing Director, Orchid said, “This is a great milestone in our US Generics journey.

Pages